Advertisement

Topics

Pernix Therapeutics Inc. to Report Second Quarter 2015 Financial Results on Thursday, August 6, 2015

20:00 EDT 23 Jul 2015 | Globe Newswire

MORRISTOWN, N.J., July 24, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that it will release its 2015 second quarter financial results on Thursday, August 6, 2015, before the market opens.

Doug Drysdale, Chairman and Chief Executive Officer, and Sanjay Patel, Chief Financial Officer, will host a conference call to discuss the results as follows:

Date: Thursday, August 6, 2015
Time: 8:30 A.M. EDT
Toll free (U.S.)          877-312-8783
International 408-940-3874

The presentation will be webcast and available on the Investors section of the Company's website at http://www.pernixtx.com/investors/webcasts-presentations/. A replay of the webcast will be available for 30 days after the date of the presentation.

About Pernix Therapeutics

Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and pain management, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its two Pernix sales forces and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.

To learn more about Pernix Therapeutics, visit www.pernixtx.com.

CONTACT: Investor Relations
         Sanjay Patel, (800) 793-2145 ext. 1009
         Chief Financial Officer
         spatel@pernixtx.com
         
         Lisa Wilson, 212-452-2793
         In-Site Communications
         lwilson@insitecony.com
         
         Media Relations
         Marianne Lambertson, (800) 793-2145 ext. 1012
         Vice President, Marketing and Corporate Communications
         mlambertson@pernixtx.com

Pernix Therapeutics, Inc. logo

NEXT ARTICLE

More From BioPortfolio on "Pernix Therapeutics Inc. to Report Second Quarter 2015 Financial Results on Thursday, August 6, 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...